The immune modulation of Bacillus cereus var. Toyoi in mice immunized with experimental inactivated Bovine Herpesvirus Type 5 vaccine

Vaccine. 2012 Mar 9;30(12):2173-7. doi: 10.1016/j.vaccine.2012.01.007. Epub 2012 Jan 26.

Abstract

In recent years, there been significant progress toward develop more efficient vaccines. Different compounds with adjuvant capacity have been tested; however, no compound has emerged that suitable for universal use. Several efforts have been made to produce effective vaccines against Bovine herpesvirus 5 (BoHV-5), an important cattle pathogen. In this study we examine the use the probiotic Bacillus cereus var. Toyoi as a potential adjuvant to improve BoHV-5 vaccine efficacy. We observed in the supplemented animals a systemic enhanced IgG antibody response toward Th1, and increased IFN-γ, IL-12 and IL-10 cytokines mRNA levels. These results suggest that this probiotic could provide a promising means of improving vaccine efficacy, particularly those vaccines that rely on a cell-mediated immune response.

MeSH terms

  • Animals
  • Antibodies, Viral / blood
  • Bacillus cereus / immunology*
  • Female
  • Gene Expression
  • Herpesvirus 5, Bovine / immunology*
  • Herpesvirus Vaccines / administration & dosage
  • Herpesvirus Vaccines / immunology*
  • Immunoglobulin G / blood
  • Immunologic Factors / pharmacology*
  • Interferon-gamma / biosynthesis
  • Interleukin-10 / biosynthesis
  • Interleukin-12 / biosynthesis
  • Mice
  • Mice, Inbred BALB C
  • Probiotics / pharmacology*

Substances

  • Antibodies, Viral
  • Herpesvirus Vaccines
  • Immunoglobulin G
  • Immunologic Factors
  • Interleukin-10
  • Interleukin-12
  • Interferon-gamma